1. Allogeneic Stem Cell Transplantation (Allo-SCT) for the Treatment of T-Cell Acute Lymphoblastic Leukemia (T-ALL); Evaluation of Minimal Residual Disease and Prognostic Factors at the MD Anderson Cancer Center (MDACC) 
Jonathan E. Brammer, MD, Rima Saliba, PhD, Hagop Kantarjian, Deborah Thomas, MD, Jeffrey L. Jorgensen, MD, Sameh Gaballa, MD, Celina Ledesma, BS, Uday R. Popat, MD, Elizabeth J. Shpall, MD, Richard E. Champlin, MD, Chitra Hosing, MD, Partow Kebriaei, MD 
Biology of Blood and Marrow Transplantation 
Volume 21, Issue 2, (February 2015)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © Terms and Conditions